CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia
- Resource Type
- Journal
- Source
MOLECULAR THERAPY ; DEC 2 2020, 28 12, p2621-p2634, 14p.- Subject
- Language
- English
- ISSN
- 15250024